Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma

Korean J Intern Med. 2016 May;31(3):605-7. doi: 10.3904/kjim.2014.305. Epub 2016 Mar 12.

Authors

Hyungwoo Cho¹, Dok Hyun Yoon², Jwa Hoon Kim¹, Young Bo Ko¹, Byoung Soo Kwon¹, In-Hye Song³, Cheolwon Suh²

Affiliations

¹ Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
² Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
³ Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

No abstract available

Keywords: Lymphoma, non-Hodgkin; Sarcoidosis; Sarcoidosis-lymphoma syndrome.

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Murine-Derived / administration & dosage
Antibodies, Monoclonal, Murine-Derived / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Biopsy
Cyclophosphamide / administration & dosage
Cyclophosphamide / therapeutic use
Doxorubicin / administration & dosage
Doxorubicin / therapeutic use
Female
Genital Neoplasms, Female / complications
Genital Neoplasms, Female / diagnosis
Genital Neoplasms, Female / drug therapy*
Humans
Lymph Nodes* / diagnostic imaging
Lymph Nodes* / pathology
Lymphoma, Large B-Cell, Diffuse / complications
Lymphoma, Large B-Cell, Diffuse / diagnosis
Lymphoma, Large B-Cell, Diffuse / drug therapy*
Middle Aged
Positron-Emission Tomography
Prednisone / administration & dosage
Prednisone / therapeutic use
Remission Induction
Rituximab / administration & dosage
Sarcoidosis / diagnostic imaging
Sarcoidosis / etiology*
Sarcoidosis / pathology
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Vincristine / administration & dosage
Vincristine / therapeutic use

Substances

Antibodies, Monoclonal, Murine-Derived
R-CHOP protocol
Rituximab
Vincristine
Doxorubicin
Cyclophosphamide
Prednisone